Showing 1-26 of 26 resultados for "S3386"
Adam Asarch et al.
Dermatitis : contact, atopic, occupational, drug, 19(6), 323-327 (2009-01-13)
In the past, sorbitan sesquioleate (SSO) was reported as an uncommon allergen, but recent data suggest SSO may be an important sensitizer. To present data on 13 of 112 dermatitis patients who reacted to SSO and/or sorbitan monooleate (SMO) on...
Contact dermatitis due to emulsifiers.
F Pereira et al.
Contact dermatitis, 36(2), 114-114 (1997-02-01)
Allergic contact dermatitis to sorbitan sesquioleate in Adaptic wound dressing.
F B de Waard-van der Spek et al.
Contact dermatitis, 57(1), 54-56 (2007-06-20)
Allergic contact dermatitis caused by sorbitan sesquioleate imitating severe glove dermatitis in a patient with filaggrin mutation.
Marianne Hald et al.
Contact dermatitis, 69(5), 313-315 (2013-10-15)
Y H Lin et al.
Journal of microencapsulation, 17(1), 1-11 (2000-02-12)
Microencapsulation of 5-fluorouracil was successfully accomplished with poly(ortho ester) polymers by the emulsification-solvent evaporation method. While actual drug loading increased with increasing drug load (5-15% w/w), the entrapment efficiency remained essentially unaffected, under a given set of experimental conditions. Incorporation...
Contact urticaria syndrome from sorbitan sesquioleate in a corticosteroid ointment.
M P Hardy et al.
Contact dermatitis, 32(2), 114-114 (1995-02-01)
Allergic contact dermatitis to sorbitan sesquioleate in children.
Mari Paz Castanedo-Tardan et al.
Contact dermatitis, 58(3), 171-172 (2008-02-19)
Sorbitan sesquioleate: an emerging contact allergen
Asarch A and Scheinman PL
Dermatitis : Contact, Atopic, Occupational, Drug : Official Journal of the American Contact Dermatitis Society, North American Contact Dermatitis Group, 19(6), 339-341 (2008)
Brienne D Cressey et al.
Dermatitis : contact, atopic, occupational, drug, 23(4), 158-161 (2012-07-26)
Sorbitan sesquioleate (SSO), an emulsifier in many corticosteroids, was previously found positive in 8.9% of 112 dermatitis patients. The objective of this study was to present data on 24 of 591 dermatitis patients with reactions to SSO and/or sorbitan monooleate...
S Fukanoki et al.
The Journal of veterinary medical science, 62(6), 571-574 (2000-07-25)
The relationship between release properties of the model antigen, bovine serum albumin (BSA), from formulations in vitro and immune response after administration of various oil adjuvanted vaccines containing liquid paraffin was examined in chickens. The vaccine prepared at an hydrophile-lipophile-balance...
P J Frosch et al.
Contact dermatitis, 32(5), 266-272 (1995-05-01)
In a multicentre study, the value of adding sorbitan sesquioleate (SSO) to the constituents of the 8% fragrance mix (FM) was investigated. In 7 centres, 709 consecutive patients were tested with 2 types of FM from different sources, its 8...
A case of "contact allergy to corticosteroid.".
C Green et al.
Contact dermatitis, 28(1), 39-40 (1993-01-01)
S Fukanoki et al.
Avian diseases, 44(4), 869-873 (2001-02-24)
The relationship between the antigen release from formulations in vitro and the antibody response after administration of water-in-oil-in-water (W/O/W) emulsion vaccines containing Haemophilus paragallinarum (Hpg) was studied in chickens. Increases of sorbitan sesquioleate volume in the formulation led to slower...
Sorbitan sesquioleate as an allergen.
D I Orton et al.
Contact dermatitis, 44(3), 190-191 (2001-02-24)
Contact urticaria syndrome from sorbitan sesquioleate in a corticosteroid ointment.
M Hardy et al.
Contact dermatitis, 32(6), 360-361 (1995-06-01)
The Validity of Patch Testing
Lachapelle JM, et al.
Patch Testing Tips, 49(4), 37-61 (2014)
Patch testing with fragrance-mix and its constituents: discrepancies are largely due to the presence or absence of sorbitan sesquioleate.
F Enders et al.
Contact dermatitis, 24(3), 238-239 (1991-03-01)
Sorbitan sesquioleate--a potential allergen in leg ulcer patients.
E Mallon et al.
Contact dermatitis, 30(3), 180-181 (1994-03-01)
Adam Asarch et al.
Dermatitis : contact, atopic, occupational, drug, 19(6), 339-341 (2009-01-13)
Sorbitol-based emulsifiers such as sorbitan sesquioleate (SSO) are commonly used in topical corticosteroids, topical antibiotics, topical antifungals, moisturizing creams and lotions, and topical retinoids. Contact dermatitis from sorbitol derivatives appears to be increasingly prevalent. Patch-testing with SSO can be useful...
E Larmi et al.
Contact dermatitis, 19(5), 368-371 (1988-11-01)
In order to study the effects of an emulsifier on non-immunologic immediate contact reactions, 500, 250, 125, 62, and 31 mM benzoic acid (BA) was tested in 12 medical students on a skin area of the upper back treated with...
M Iwata et al.
Journal of microencapsulation, 16(1), 49-58 (1999-02-11)
PLGA multiphase microspheres were prepared by the multiple emulsion solvent evaporation method using acetonitrile as the polymer solvent and mineral oil as the evaporation medium. The preparation process was further developed in the present study to reduce the particle size...
Contact dermatitis.
Flora B de Waard-van der Spek et al.
Contact dermatitis, 59(1), 67-67 (2008-07-05)
Kinetic evaluation of biotransformation of benzaldehyde to L-phenylacetylcarbinol by immobilized pyruvate decarboxylase from Candida utilis
Shin HS and Rogers PL
Biotechnology and Bioengineering, 49(4), 429-436 (1996)
Jacquelyn Coloe et al.
Dermatitis : contact, atopic, occupational, drug, 19(1), 38-42 (2008-03-19)
Whereas allergy to vehicle ingredients (ie, excipients and preservatives) in topical steroid vehicles is well recognized, there are no data regarding which vehicle ingredients are in common use or on which vehicles and active molecules are associated with which ingredients....
Abhishek Shrivastava et al.
Proceedings of the National Academy of Sciences of the United States of America, 115(34), 8633-8638 (2018-08-08)
The human microbiome is an assemblage of diverse bacteria that interact with one another to form communities. Bacteria in a given community are arranged in a 3D matrix with many degrees of freedom. Snapshots of the community display well-defined structures...
Sorbitan sesquioleate.
Mari Paz Castanedo-Tardan et al.
Dermatitis : contact, atopic, occupational, drug, 19(4), E22-E23 (2008-08-05)

Redes sociais

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Pesquisa. Desenvolvimento. Produção.

Somos um fornecedor global líder para o setor de ciências biológicas, com soluções e serviços para pesquisa, desenvolvimento e produção de biotecnologia, além de produção e desenvolvimento de terapias farmacológicas com medicamentos.

© 2021 Merck KGaA, Darmstadt, Alemanha e/ou suas filiais. Todos os direitos reservados.

A reprodução não autorizada de quaisquer materiais deste site é estritamente proibida.